Microbot Medical Stock (NASDAQ:MBOT)


RevenueOwnershipFinancialsChart

Previous Close

$0.93

52W Range

$0.82 - $2.35

50D Avg

$0.94

200D Avg

$1.03

Market Cap

$16.59M

Avg Vol (3M)

$154.51K

Beta

1.63

Div Yield

-

MBOT Company Profile


Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.

Show More

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

21

IPO Date

Mar 25, 1992

Website

MBOT Performance


MBOT Financial Summary


Dec 23Dec 22Dec 21
Revenue---
Operating Income---
Net Income---
EBITDA---
Basic EPS---
Diluted EPS---

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q2 17Aug 14, 17 | 12:00 AM
Q4 15Mar 24, 16 | 2:16 PM
Q2 15Aug 08, 15 | 10:34 AM

Peer Comparison


TickerCompany
SDCSmileDirectClub, Inc.
ZJYLJin Medical International Ltd.
BDXBecton, Dickinson and Company
WSTWest Pharmaceutical Services, Inc.
GMVDG Medical Innovations Holdings Ltd
GCTKGlucoTrack, Inc.
RMDResMed Inc.
MHUAMeihua International Medical Technologies Co., Ltd.
POAIPredictive Oncology Inc.
ISRGIntuitive Surgical, Inc.
STAASTAAR Surgical Company
STSSSharps Technology, Inc.